102 related articles for article (PubMed ID: 9722729)
1. Tumor vascularity, proliferation, and apoptosis in human melanoma micrometastases and macrometastases.
Barnhill RL; Piepkorn MW; Cochran AJ; Flynn E; Karaoli T; Folkman J
Arch Dermatol; 1998 Aug; 134(8):991-4. PubMed ID: 9722729
[TBL] [Abstract][Full Text] [Related]
2. Biological behavior of human breast cancer micrometastases.
Klauber-DeMore N; Van Zee KJ; Linkov I; Borgen PI; Gerald WL
Clin Cancer Res; 2001 Aug; 7(8):2434-9. PubMed ID: 11489823
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma.
Barnhill RL; Fandrey K; Levy MA; Mihm MC; Hyman B
Lab Invest; 1992 Sep; 67(3):331-7. PubMed ID: 1383607
[TBL] [Abstract][Full Text] [Related]
4. The biology of melanoma micrometastases.
Barnhill RL
Recent Results Cancer Res; 2001; 158():3-13. PubMed ID: 11092028
[TBL] [Abstract][Full Text] [Related]
5. Stochastic relationship between the growth fraction and vascularity of thin malignant melanomas.
Piérard GE; Piérard-Franchimont C
Eur J Cancer; 1997 Oct; 33(11):1888-92. PubMed ID: 9470852
[TBL] [Abstract][Full Text] [Related]
6. The extent of proliferative and apoptotic activity in intraductal and invasive ductal breast carcinomas detected by Ki-67 labeling and terminal deoxynucleotidyl transferase-mediated digoxigenin-11-dUTP nick end labeling.
Shen KL; Harn HJ; Ho LI; Yu CP; Chiu SC; Lee WH
Cancer; 1998 Jun; 82(12):2373-81. PubMed ID: 9635530
[TBL] [Abstract][Full Text] [Related]
7. Regressing thin cutaneous malignant melanomas (< or = 1.0 mm) are associated with angiogenesis.
Barnhill RL; Levy MA
Am J Pathol; 1993 Jul; 143(1):99-104. PubMed ID: 7686347
[TBL] [Abstract][Full Text] [Related]
8. Angiogenic fast-growing melanomas and their micrometastases.
Quatresooz P; Pierard-Franchimont C; Paquet P; Pierard GE
Eur J Dermatol; 2010; 20(3):302-7. PubMed ID: 20413369
[TBL] [Abstract][Full Text] [Related]
9. Nuclear morphometry of MIB-1 positive and negative tumor cells in primary and metastatic malignant melanoma of the skin.
Karbowniczek M; Chosia M; Domagała W
Pol J Pathol; 1999; 50(4):235-41. PubMed ID: 10721263
[TBL] [Abstract][Full Text] [Related]
10. Apoptotic and proliferating cells in cutaneous lymphoproliferative diseases.
Kikuchi A; Nishikawa T
Arch Dermatol; 1997 Jul; 133(7):829-33. PubMed ID: 9236520
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of tumour vascularity as a prognostic indicator in uveal melanoma.
Lane AM; Egan KM; Yang J; Saornil MA; Alroy J; Albert D; Gragoudas ES
Melanoma Res; 1997 Jun; 7(3):237-42. PubMed ID: 9195563
[TBL] [Abstract][Full Text] [Related]
12. Tumor vascularity is not a prognostic factor for malignant melanoma of the skin.
Busam KJ; Berwick M; Blessing K; Fandrey K; Kang S; Karaoli T; Fine J; Cochran AJ; White WL; Rivers J
Am J Pathol; 1995 Oct; 147(4):1049-56. PubMed ID: 7573350
[TBL] [Abstract][Full Text] [Related]
13. MIB-1 immunoreactivity correlates with metastatic dissemination in primary thick cutaneous melanoma.
Böni R; Doguoglu A; Burg G; Müller B; Dummer R
J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):416-8. PubMed ID: 8784279
[TBL] [Abstract][Full Text] [Related]
14. Dermal vascularity in lentigo maligna.
Trotter MJ; Tron VA
J Pathol; 1994 Aug; 173(4):341-5. PubMed ID: 7525908
[TBL] [Abstract][Full Text] [Related]
15. MIB-1 immunoreactivity correlates with blood vessel density and survival in disseminated malignant melanoma.
Vlaykova T; Talve L; Hahka-Kemppinen M; Hernberg M; Muhonen T; Franssila K; Collan Y; Pyrhönen S
Oncology; 1999 Oct; 57(3):242-52. PubMed ID: 10545794
[TBL] [Abstract][Full Text] [Related]
16. Multiorgan Involvement of Dormant Uveal Melanoma Micrometastases in Postmortem Tissue From Patients Without Coexisting Macrometastases.
Gill VT; Norrman E; Sabazade S; Karim A; Lardner E; Stålhammar G
Am J Clin Pathol; 2023 Aug; 160(2):164-174. PubMed ID: 37052618
[TBL] [Abstract][Full Text] [Related]
17. Tumour vascularity is not a prognostic factor for cutaneous melanoma.
Barnhill RL; Busam KJ; Berwick M; Blessing K; Cochran AJ; Elder DE; Fandrey K; Karaoli T; White WL
Lancet; 1994 Oct; 344(8931):1237-8. PubMed ID: 7934572
[No Abstract] [Full Text] [Related]
18. The vascularity of cutaneous melanoma: a quantitative histological study of lesions 0.85-1.25 mm in thickness.
Carnochan P; Briggs JC; Westbury G; Davies AJ
Br J Cancer; 1991 Jul; 64(1):102-7. PubMed ID: 1854608
[TBL] [Abstract][Full Text] [Related]
19. Sentinel-node biopsy or nodal observation in melanoma.
Morton DL; Thompson JF; Cochran AJ; Mozzillo N; Elashoff R; Essner R; Nieweg OE; Roses DF; Hoekstra HJ; Karakousis CP; Reintgen DS; Coventry BJ; Glass EC; Wang HJ;
N Engl J Med; 2006 Sep; 355(13):1307-17. PubMed ID: 17005948
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study.
Srivastava A; Laidler P; Davies RP; Horgan K; Hughes LE
Am J Pathol; 1988 Nov; 133(2):419-23. PubMed ID: 3189515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
